Trials / NCT04127006
Rate of Progression in EYS Related Retinal Degeneration
Underway, not enrolling Observational Natural history / observational
- Sponsor
- Jaeb Center for Health Research
- Treatment
- Not listed
- Gene
- EYS
- Conditions
- Retinitis Pigmentosa, Eye Diseases
- Ages
- 18 Years to no upper limit
- Enrollment
- 103 participants
- Started
- 2020-02-25
- Main results expected
- 2026-02-09
- Results posted
- Not yet
- Record last updated
- 2026-10-29
What the study is testing
The overall goal of this project funded by the Foundation Fighting Blindness is to characterize the natural history of disease progression in patients with EYS mutations in order to accelerate the development of outcome measures for clinical trials.
Where it runs
Canada (1)
- Hospital for Sick Children, Toronto
Finland (1)
- Helsinki University Hospital, Helsinki
France (1)
- Centre hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris
Germany (1)
- University of Tubingen, Tübingen
Israel (1)
- Hadassah Medical Center, Jerusalem, Israel
Netherlands (1)
- Radboud University, Nijmegen
United States (13)
- University of California, San Francisco, San Francisco, California
- Colorado Retina Associates, Denver, Colorado
- Vitreo-Retinal Associates, Gainesville, Florida
- University of Miami: Neuro-ophthalmology Department, Miami, Florida
- Emory Eye Center, Atlanta, Georgia
- Wilmer Eye Institute at Johns Hopkins, Baltimore, Maryland
- Massachusetts Eye and Ear, Boston, Massachusetts
- Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan
- Duke University Eye Center, Durham, North Carolina
- Oregon Health Science University Casey Eye Institute, Portland, Oregon
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
- Retina Foundation of the Southwest, Dallas, Texas
- University of Wisconsin-Madison: McPherson Eye Research Institute, Madison, Wisconsin